Hey, I’m Amy and I’m from Sligo! I studied Physiology and Microbiology for my undergraduate degree. I recently completed my Professional Masters of Education at NUI Galway, where I specialised in Biology, Science and Mathematics.
I thought this would be a great opportunity to enhance my skills and knowledge through an enriching and positive experience learning about real life science in industry. I hope that I will learn new skills and build connections that will aid me in developing innovative ideas for teaching and learning as well as inspiring students to create a future workforce in STEM.
During my internship, I got the chance to work effectively as part of a team. My team at VLE Therapeutics was responsible for the preparation of Standard Operating Procedures as well as training modules to aid in the running of VLE’s new GMP Facility.
APC was created out of a passion for science and research. In 2011, Dr. Mark Barrett and Prof. Brian Glennon of the UCD School of Chemical and Bioprocess Engineering in Dublin, Ireland, embarked on a mission to disrupt the pharma and biotech industries with a hyper-focused, accelerated approach to drug process development. APC has grown organically to become a global powerhouse in process development, partnering with companies large and small to bring medicines to market at unprecedented speed.
APC has created a new company, VLE Therapeutics, to support the manufacture of vaccines and advanced therapeutics for clinical and commercial supply. A Stage 1 investment is targeted to deliver an operational GMP manufacturing capability by the end of 2021. The leadership and operations team is currently being expanded in line parallel with the facility design and build. A Stage 2 will deliver a new bespoke 80,000 ft2 manufacturing facility by the end of 2023. The facility will provide a world-class platform for the GMP manufacture of a wide range of vaccines and advanced therapeutics.